Yantai Zhenghai Bio-Tech Co Ltd (300653) — Cash Flow Quality Index

Latest as of September 2025: 1.46x

Yantai Zhenghai Bio-Tech Co Ltd (300653) has a Cash Flow Quality Index of 1.46x as of September 2025. Operating cash flow of CN¥30.47 Million exceeds net income of CN¥20.92 Million, indicating high earnings quality where cash backs reported profits. Also explore Yantai Zhenghai Bio-Tech Co Ltd (300653) total assets for the complete picture of this company's asset base.

Cash Flow Quality Index

1.46x
Operating CF / Net Income

Operating Cash Flow

CN¥30.47 Million
CNY

Net Income

CN¥20.92 Million
CNY

Data as of

Sep 2025
Most recent filing

Yantai Zhenghai Bio-Tech Co Ltd Cash Flow Quality Index (2013–2024)

Historical Cash Flow Quality Index for Yantai Zhenghai Bio-Tech Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Yantai Zhenghai Bio-Tech Co Ltd to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Yantai Zhenghai Bio-Tech Co Ltd (2013–2024)

Year-by-year earnings quality comparison for Yantai Zhenghai Bio-Tech Co Ltd. For live market cap and the full company financial profile, see 300653 company net worth.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2024 1.12x CN¥151.38 Million CN¥134.64 Million ▲ +19.0%
2023 0.95x CN¥180.48 Million CN¥190.96 Million ▼ -6.7%
2022 1.01x CN¥187.84 Million CN¥185.44 Million ▲ +2.8%
2021 0.99x CN¥166.13 Million CN¥168.55 Million ▼ -1.5%
2020 1.00x CN¥118.43 Million CN¥118.33 Million ▲ +3.9%
2019 0.96x CN¥103.48 Million CN¥107.39 Million ▲ +6.7%
2018 0.90x CN¥77.47 Million CN¥85.82 Million ▼ -15.0%
2017 1.06x CN¥65.47 Million CN¥61.67 Million ▼ -2.0%
2016 1.08x CN¥49.25 Million CN¥45.47 Million ▲ +0.6%
2015 1.08x CN¥45.74 Million CN¥42.49 Million ▲ +17.7%
2014 0.91x CN¥30.79 Million CN¥33.66 Million ▼ -58.1%
2013 2.18x CN¥34.38 Million CN¥15.77 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.